Anti-Parkinson efficacy (l-dopa sparing effect) of ropinirole versus placebo as adjunct therapy in parkinsonian patients not optimally controlled on l-dopa

Authors
Category Primary study
Year 1990
This article has no abstract
Epistemonikos ID: 0b17a40d861e9ffc03b18f3a18c58ec1f1806177
First added on: Apr 19, 2017